Navigation Links
Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem
Date:3/8/2012

tributed, thereby providing a solid safety and efficacy track record. Pevion has developed and owns the second generation of virosomes, which have an excellent stability profile through lyophilization and allow alternative product formulations, such as capsules.

About Pevion Biotech AG

Pevion Biotech AG is a fully independent Swiss vaccine company that develops innovative vaccines for unmet medical needs based on its clinically and commercially validated virosome technology. Its proprietary clinical pipeline includes a first-in-class candidiasis vaccine. A clinical stage malaria vaccine candidate has been successfully out-licensed, and the Company's technology has been out-licensed for use as an HIV vaccine, currently in human trials. Pevion has in-house development capability and expertise, including a state-of-the-art and industrially scalable GMP manufacturing process. Located near Bern, Pevion was established by two founding companies, Bachem AG (SWX: BANB) and Berna Biotech (now Crucell, a Johnson & Johnson subsidiary). To date, Pevion has raised a total of CHF 45 million from its founders and investors, BZ Bank, Bachem, BB Biotech Ventures and private investors.

For more information, please visit http://www.pevion.com

For further information, please contact:

Julian Wagner, PhD, BBA, Business Development
Phone: +41-31-550-44-44, info@pevion.com


'/>"/>
SOURCE Pevion Biotech AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pevion Biotech Appoints New CEO and Secures CHF 10 Million Financing
2. Pevions Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study
3. Pevion Grants CSL Option Right to its Therapeutic Candida Vaccine
4. Pevions Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... MENLO PARK, Calif. , Aug. 19, 2014 ... company") announced today a protocol amendment to allow for expanded ... the U.S. Food and Drug Administration (FDA) and that a ... opened at three clinical trial sites in the ... proceeds of US$2.9 million have been raised through warrant exercise ...
(Date:8/19/2014)... 19, 2014 ,Weight Loss- Market ... 2014, report provides comprehensive insights about phase III pipeline ... objective of the report is to establish the understanding ... drugs across the different countries and regions. While the ... report also provides details on the drug master filings ...
(Date:8/18/2014)... and HERZLIYA-PITUACH, Israel , Aug. 19, 2014 ... North Premier, Stockholm : "IMNP"), a biotechnology ... application to list its common stock on the NASDAQ Capital ... unit of the NASDAQ OMX Group. IMMUNE,s common stock is ... the opening of trading on August 21, 2014 under the ...
Breaking Medicine Technology:DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 2DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 4DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 5DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 6DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 7Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 2Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 3Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 4Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 2Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 3Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 4
... Dec. 27, 2011 Neuralstem, Inc. (NYSE Amex: ... Food and Drug Administration to advance to Phase Ib in ... NSI-189, for the treatment of major depressive disorder ... the drug in depressed patients. NSI-189 is a proprietary new ...
... Dec. 27, 2011 /PRNewswire-Asia/ -- China Botanic Pharmaceutical ... Botanic" or the "Company"), a developer, manufacturer and ... Medicines ("TCM") in China, today announced that the ... 66th PHARMCHINA fair ("the Fair") recently held in ...
Cached Medicine Technology:Neuralstem's NSI-189 Trial in Major Depressive Disorder Receives FDA Approval to Advance to Phase Ib 2Neuralstem's NSI-189 Trial in Major Depressive Disorder Receives FDA Approval to Advance to Phase Ib 3Neuralstem's NSI-189 Trial in Major Depressive Disorder Receives FDA Approval to Advance to Phase Ib 4China Botanic Exhibits All-Natural Anti-depressant Products at the 66th PHARMCHINA Fair 2China Botanic Exhibits All-Natural Anti-depressant Products at the 66th PHARMCHINA Fair 3
(Date:8/20/2014)... they often have difficulty falling asleep and staying asleep, ... In individuals with Alzheimer,s disease, this common and troubling ... leading to nighttime confusion and wandering. , Now, a ... Center (BIDMC) and the University of Toronto/Sunnybrook Health Sciences ... age. Reported online today in the journal Brain ...
(Date:8/20/2014)... Los Angeles, CA (PRWEB) August 20, 2014 ... will honor the 2014 Emmy Award Nominees and Presenters at ... place on August 22nd and 23rd in Beverly Hills from ... enjoy gifts, refreshments and music by DJ Morgan Hildebrand. , ... charity fundraising and will feature several charities at the lounge. ...
(Date:8/20/2014)... Kowa Optimed returns after a short ... the new SL-17 portable slit lamp. , The SL-17 ... source controlled by an illuminated thumb wheel for easy ... commercially available AAA rechargeable and dry cell batteries, which ... batteries designed specifically for the device. The new Sl-17 ...
(Date:8/20/2014)... York (PRWEB) August 20, 2014 Over 31 ... Global Bureau of Disease, low back pain is the single ... most common reasons for missed work. Americans spend at least ... pain. , Most cases of back pain are not due ... (non-organic) origin. , For example, Pete, a busy accountant, had ...
(Date:8/19/2014)... (PRWEB) August 20, 2014 As moms and ... for themselves to return to the normal routine of dropping ... in tow, Kristen Yarker, MSc, RD encourages them to ... their kids’ snack time. , Yarker explains, “Kids have ... nutrients. Instead of giving them junk food handouts, use snack ...
Breaking Medicine News(10 mins):Health News:Research helps explain why elderly have trouble sleeping 2Health News:Research helps explain why elderly have trouble sleeping 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 2Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 4Health News:Kowa Optimed (Booth MS13043) to Debut New Portable Slit Lamp at 2014 Vision Expo West in Las Vegas, Nevada 2Health News:Physical Therapists Learn to Relieve Low Back Pain 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3
... of stroke victims suffer vision difficulties due to cortical ... holds immense promise for patients suffering partial impairment of ... medical instrument has been devised that is capable of ... This could indeed be the light at the end ...
... gene expression in the mouse brain is considered a scientific ... or 57.7 million people//. , ,The Allen Institute ... The Allen Institute was started in 2003 and the Atlas ... given by Microsoft co-founder Paul G. Allen funded both. ...
... Sufferers,Television personality Angela Rippon is fronting a new DVD ... Chronic Obstructive Pulmonary Disease (COPD). The DVD called Move ... ,COPD includes a range of lung diseases like chronic ... make a difference to the lives of people living ...
... HIV/AIDS is a major hindrance in controlling the fast-spreading disease ... discrimination are indeed problem areas in tackling HIV/AIDS in India," ... for HIV/AIDS in Asia and the Pacific. ,"There ... lots needs to be done to make it (the disease) ...
... for the cartoon man, Popeye, who simply preens at the ... spinach and an icon that little kids swear by, what ... who still boasts of a perfect vision without the help ... with a novel eye device are trying to understand the ...
... Drug Administration takes days to track down the source of ... sensor that can enable growers to do the job themselves ... engineering at Drexel University, has developed an “intelligent” sensor technology ... dollars, the sensor can provide a result within 10 minutes ...
Cached Medicine News:Health News:Allen Brain Atlas – a 3-D gene map of brai 2Health News:Remove Stigma to Defeat HIV/AIDS in India, says UN Envoy 2Health News:Go Green with Popeye: Learn why his eyes pop out for spinach! 2
The Redi-glaze spectacle magnifier is an aspheric lens, glazed into a standard Keeler LVA frame....
This set is designed to introduce the low vision practitioner to the Keeler telescopic system....
... Featuring up to 20 ... examination in the vertical, ... plus the option to ... corneal transillumination., ,Filters include ...
Comes complete in its own carrying case. There are 24 lenses, 13mm diameter -6D to +6D in 0.5D steps. Mounted in tough, yet light alloy frame....
Medicine Products: